D.L. Carlson Investment Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-94,810
| Closed | -$6.92M | – | 158 |
|
|
2023
Q3 | $6.92M | Sell |
94,810
-8,888
| -9% | -$649K | 1.4% | 20 |
|
|
2023
Q2 | $8.63M | Buy |
103,698
+153
| +0.1% | +$12.7K | 1.65% | 13 |
|
|
2023
Q1 | $7.89M | Buy |
103,545
+17,826
| +21% | +$1.36M | 1.79% | 10 |
|
|
2022
Q4 | $7.12M | Buy |
85,719
+2,387
| +3% | +$198K | 1.53% | 20 |
|
|
2022
Q3 | $6.61M | Buy |
83,332
+19,536
| +31% | +$1.55M | 1.44% | 17 |
|
|
2022
Q2 | $4.74M | Buy |
63,796
+19,685
| +45% | +$1.46M | 1% | 37 |
|
|
2022
Q1 | $3.97M | Buy |
44,111
+156
| +0.4% | +$14K | 0.66% | 58 |
|
|
2021
Q4 | $4.92M | Buy |
43,955
+7,054
| +19% | +$790K | 0.79% | 49 |
|
|
2021
Q3 | $4.64M | Buy |
36,901
+55
| +0.1% | +$6.91K | 0.81% | 45 |
|
|
2021
Q2 | $4.99M | Buy |
36,846
+129
| +0.4% | +$17.5K | 0.86% | 47 |
|
|
2021
Q1 | $4.98M | Sell |
36,717
-39,882
| -52% | -$5.41M | 0.91% | 47 |
|
|
2020
Q4 | $10.8M | Buy |
76,599
+3,469
| +5% | +$488K | 1.96% | 11 |
|
|
2020
Q3 | $8.15M | Buy |
73,130
+19,137
| +35% | +$2.13M | 1.72% | 17 |
|
|
2020
Q2 | $6.05M | Buy |
53,993
+2,740
| +5% | +$307K | 1.8% | 13 |
|
|
2020
Q1 | $3.97M | Buy |
51,253
+4,438
| +9% | +$344K | 1.5% | 17 |
|
|
2019
Q4 | $4.45M | Buy |
46,815
+943
| +2% | +$89.7K | 1.29% | 26 |
|
|
2019
Q3 | $3.5M | Sell |
45,872
-60
| -0.1% | -$4.58K | 1.1% | 34 |
|
|
2019
Q2 | $4.03M | Sell |
45,932
-5,145
| -10% | -$451K | 1.24% | 28 |
|
|
2019
Q1 | $4.63M | Buy |
51,077
+29,147
| +133% | +$2.64M | 1.35% | 23 |
|
|
2018
Q4 | $1.57M | Sell |
21,930
-19,465
| -47% | -$1.4M | 0.52% | 73 |
|
|
2018
Q3 | $3.97M | Buy |
+41,395
| New | +$3.97M | 1.12% | 36 |
|